|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 96, 757-760, Copyright © 1989 by American College of Chest Physicians
ARTICLES |
H Asari, H Kondo, A Ishihara, K Ando and F Marumo
Department of Cardiac Surgery, Kitasato University School of Medicine, Kitasato Biochemical Laboratories, Sagamihara, Japan.
An attempt was made to clarify the change of plasma human atrial natriuretic peptide (hANP) concentration before, during, and after cardiac surgery in heart failure with extracorporeal circulation. Plasma hANP concentration did not significantly decrease during total aortic cross clamping (ACC) with complete clamping of the superior and inferior vena cavae. This finding may be explained by the suppression of endopeptidase activities and the response of hANP receptors due to the low body temperature. Plasma hANP concentration strongly increased from 56.6 +/- 8.4 to 208.9 +/- 40.7 pg/ml (n = 5) by the release of total ACC. This strong increase of hANP in the plasma may occur due to the rapid increase of atrial pressure from zero to 12.5 mm Hg caused by releasing the total ACC. The molecular form of plasma hANP obtained after the release of total ACC was alpha-hANP alone, which was estimated by gel permeation chromatography and reverse HPLC.
This article has been cited by other articles:
![]() |
I. Rubinstein and F. D. Hong Circulating Natriuretic Peptides : A Biologic Marker of Tissue Injury? Chest, January 1, 1999; 115(1): 7 - 8. [Full Text] [PDF] |
||||
![]() |
H. Berkenstadt, T. Rosenthal, E. Peleg, E. Segal, A. Hackshaw, G. Ben-Ari, and A. Perel Elevated Plasma Atrial Natriuretic Peptide Levels After Occlusion of the Thoracic Aorta Chest, January 1, 1999; 115(1): 130 - 134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |